Marketometer

Short

Trend Resistance

Uptrend Above: 25030

Bull Market Above: 25210

Term

Mid Point Acts

Mid Point: 25200

Mid Range: 24680 - 25200

View

Trend Suport

Down Trend Below: 24420

Bear Market Below: 24290

Short Term View Historic Data

Nifty View On: Monday 20 Oct 2025

Day Close 25709	Day High 25781	Day Low 25508	Day Avg 25666	17 Oct 2025	5 SMA 25398	20 SMA 25098	50 SMA 24929	100 SMA 24986	200 SMA 24230
Dhas 0.25	Macs 17.25	Dwad 0.01	Mpas 0	Monday View	Resist 2 26070	Resist 1 25980	Mid Point 25730	Suport 1 25470	Suport 2 25400
52W High 25781	52w Low 21743	52w Down 0.28%	52w Up 18.24%	Week View	Resist 2 26410	Resist 1 26230	Mid Point 25730	Suport 1 25210	Suport 2 25080
5d High 25781	5d Low 25060	10d High 25781	10d Low 24881	Days High & Low	20d High 25781	20d Low 24587	50d High 25781	50d Low 24337	All Avg 25249

Daily And Weekly Historic Prediction Data

Nifty Last Five Days Moves

SNo.	Date	Day Close	Day High	Day Low	20 DMA	50 DMA	200 DMA	All Avg
1	17 Oct 2025	25709	25781	25508	25098	24929	24230	25209
2	16 Oct 2025	25585	25625	25376	25084	24908	24220	25133
3	15 Oct 2025	25323	25365	25159	25071	24891	24211	25003
4	14 Oct 2025	25145	25310	25060	25067	24876	24203	24944
5	13 Oct 2025	25227	25267	25152	25063	24868	24196	24962

Nifty Historic Data And Moving Avg

Go Back

Morepen Laboratories Limited. This is to inform you that pursuant to the fresh issue of equity sh...

Posted: 01 Jul 2025

Morepen Laboratories Limited. This is to inform you that pursuant to the fresh issue of equity shares by Morepen Medipath Limited (formerly known as Morepen Medtech Limited) ("MML"), a subsidiary, the company received an offer to subscribe to the equity shares. The Finance Committee of the Board of Directors of the company at its meeting held today, June 30, 2025, has, inter alia, approved the subscription of 2,00,000 (Two Lakh) equity shares under the aforesaid issue. As a result of this transaction, the company’s shareholding in MML has been reduced from 80% to 60%. The details, as required under the SEBI Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, is given under as Annexure. Sr. No. Particulars Details 1. Details and reasons for restructuring; Issue and allotment of fresh equity shares by Morepen Medipath Limited (formerly known as Morepen Medtech Limited) ("MML"), a subsidiary company, recently incorporated for carrying out the home health business. 2. Quantitative and/ or qualitative effect of restructuring; The company has subscribed 2,00,000 (Two Lakh) equity shares, under the rights issue 3. Details of benefit, if any, to the promoter/promoter group/group companies from such proposed restructuring; Pursuant to above, the shareholding of the company’s promoter group in Morepen Medipath Limited, has been increased from 20% to 40%. 4. Brief details of change in shareholding pattern (if any) of all entities. The shareholding of the Company in MML, changes as follows: Pre-Transaction Post-Transaction Name of the shareholder Number of Shares % of total paid-up share capital Number of Shares % of total paid-up share capital Morepen Laboratories Limited 8,80,000 80% 10,80,000 60% Persons belonging to promoters & promoter group of MLL and relatives thereof. 2,20,000 20% 7,20,000 40% Total 11,00,000 100% 18,00,000 100%

"In investing, what is comfortable is rarely profitable." — Robert Arnott

Be prepared to invest in a down market and to "get out" in a soaring market, as per the philosophy of Warren Buffett.

Date	Macs	Dcmp
17/10 2025	8.45	-18
16/10 2025	-1.72	-39
15/10 2025	-4.28	-53
14/10 2025	-3.77	-47
13/10 2025	-2.90	-43
10/10 2025	-9.51	-50
09/10 2025	-7.03	-62
08/10 2025	-7.37	-56
07/10 2025	1.58	-57
06/10 2025	0.45	12
03/10 2025	3.55	63
01/10 2025	1.07	-25
30/09 2025	6.41	37
29/09 2025	10.43	-8
26/09 2025	8.74	80
25/09 2025	11.46	13
24/09 2025	7.01	81

User Register

User Login

You Are Not Admin

Nifty: 25709 (124)